NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioChange

BioChange

Private
IsraelHealthcare & Life Scienceshttps://biochange.life/

Last Round

Crowdfunding

Oct 1, 2021

Company Overview

BioChange is a biotechnology company that has developed a tissue regeneration technology designed to stimulate tissue repair and remodeling at the injected site.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials, Advanced Materials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

regenerative medicinetissue engineeringbiodegradable scaffoldscaffold technologytissue regenerationveterinary medicineanimal healthbiomaterialsveterinary medical deviceinjectable scaffoldextracellular matrixperiodontal treatmenthemostatic agentmedical aestheticsdental regeneration

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioChange Comparables

Compare BioChange with similar companies based on industry and business-model similarity.

BioChange comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

BioChange Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingOct 1, 2021

Key People

Founding team and executive leadership

Iris Shichor

CEO, Co-CEO At BioChange LTD

Executive Team

BioChange Investors

Notable investors and investment history

BioChange investors
InvestorRounds
Israel Innovation AuthorityGrant
ExitValleyCrowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 4, 2026

    Monthly visitors increased 153% MoM, reaching 644.

  • May 5, 2025

    Grew 21% QoQ from 14 to 17 employees.

BioChange Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioChange Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioChange's valuation, stock price, and market status.

Firmographic Details

HeadquartersIsrael
Employee Range17
Year Founded2017
Last FundingOct 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.